AQR Capital Management’s Select Medical SEM Stock Holding History

AQR Capital Management’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.75M	Buy	166,669 +57,085	+52%	+$941K	﹤0.01%	2402
2026 Q1	$1.79M	Buy	109,584 +22,003	+25%	+$344K	﹤0.01%	2429
2025 Q4	$1.3M	Buy	87,581 +13,823	+19%	+$195K	﹤0.01%	2407
2025 Q3	$947K	Buy	73,758 +43,408	+143%	+$578K	﹤0.01%	2468
2025 Q2	$461K	Sell	30,350 -3,544	-10%	-$55.3K	﹤0.01%	2656
2025 Q1	$566K	Buy	33,894 +16,656	+97%	+$307K	﹤0.01%	2355
2024 Q4	$325K	Sell	17,238 -3,772	-18%	-$72.7K	﹤0.01%	2461
2024 Q3	$395K	Buy	21,010 +761	+4%	+$14.6K	﹤0.01%	2272
2024 Q2	$383K	Buy	20,249 +3,074	+18%	+$52.4K	﹤0.01%	2178
2024 Q1	$279K	Buy	17,175 +1,167	+7%	+$17.1K	﹤0.01%	2150
2023 Q4	$203K	Sell	16,008 -20,225	-56%	-$255K	﹤0.01%	2213
2023 Q3	$493K	Sell	36,233 -844	-2%	-$13K	﹤0.01%	1845
2023 Q2	$636K	Sell	37,077 -7,562	-17%	-$117K	﹤0.01%	1720
2023 Q1	$622K	Sell	44,639 -2,212	-5%	-$32.6K	﹤0.01%	1703
2022 Q4	$627K	Sell	46,851 -891	-2%	-$11.5K	﹤0.01%	1730
2022 Q3	$568K	Sell	47,742 -38,590	-45%	-$548K	﹤0.01%	1730
2022 Q2	$1.1M	Sell	86,332 -41,717	-33%	-$535K	﹤0.01%	1384
2022 Q1	$1.66M	Sell	128,049 -3,473	-3%	-$45.9K	﹤0.01%	1296
2021 Q4	$2.08M	Sell	131,522 -33,308	-20%	-$569K	﹤0.01%	1143
2021 Q3	$3.21M	Buy	164,830 +17,844	+12%	+$354K	0.01%	937
2021 Q2	$3.35M	Buy	146,986 +15,362	+12%	+$319K	0.01%	961
2021 Q1	$2.42M	Sell	131,624 -33,302	-20%	-$546K	﹤0.01%	1117
2020 Q4	$2.46M	Sell	164,926 -31,502	-16%	-$411K	﹤0.01%	1065
2020 Q3	$2.2M	Sell	196,428 -11,784	-6%	-$116K	﹤0.01%	1066
2020 Q2	$1.65M	Buy	208,212 +16,458	+9%	+$136K	﹤0.01%	1244
2020 Q1	$1.55M	Buy	191,754 +92,549	+93%	+$1.1M	﹤0.01%	1168
2019 Q4	$1.25M	Sell	99,205 -7,727	-7%	-$83.2K	﹤0.01%	1445
2019 Q3	$955K	Sell	106,932 -23,363	-18%	-$204K	﹤0.01%	1536
2019 Q2	$1.11M	Sell	130,295 -16,335	-11%	-$129K	﹤0.01%	1454
2019 Q1	$1.11M	Buy	146,630 +71,666	+96%	+$576K	﹤0.01%	1523
2018 Q4	$620K	Sell	74,964 -28,593	-28%	-$274K	﹤0.01%	1688
2018 Q3	$1.03M	Sell	103,557 -29,338	-22%	-$304K	﹤0.01%	1695
2018 Q2	$1.3M	Sell	132,895 -5,531	-4%	-$54.3K	﹤0.01%	1617
2018 Q1	$1.29M	Buy	138,426 +45,758	+49%	+$436K	﹤0.01%	1570
2017 Q4	$881K	Sell	92,668 -5,364	-5%	-$51.3K	﹤0.01%	1720
2017 Q3	$1.01M	Buy	98,032 +33,957	+53%	+$314K	﹤0.01%	1668
2017 Q2	$530K	Sell	64,075 -78,527	-55%	-$589K	﹤0.01%	1866
2017 Q1	$1.03M	Buy	142,602 +90,521	+174%	+$656K	﹤0.01%	1670
2016 Q4	$372K	Buy	52,081 +1,221	+2%	+$8.5K	﹤0.01%	2007
2016 Q3	$370K	Hold	50,860	–	–	﹤0.01%	2031
2016 Q2	$298K	Buy	+50,860	New	+$337K	﹤0.01%	2011
2015 Q4	–	Sell	-50,997	Closed	-$296K	–	2295
2015 Q3	$296K	Sell	50,997 -146,322	-74%	-$1.09M	﹤0.01%	1930
2015 Q2	$1.72M	Sell	197,319 -309,794	-61%	-$2.6M	﹤0.01%	1244
2015 Q1	$4.05M	Sell	507,113 -402,418	-44%	-$3.01M	0.01%	859
2014 Q4	$7.06M	Buy	909,531 +180,309	+25%	+$1.32M	0.01%	793
2014 Q3	$4.73M	Buy	729,222 +351,340	+93%	+$2.71M	0.01%	845
2014 Q2	$3.18M	Buy	377,882 +208,986	+124%	+$1.62M	0.01%	1083
2014 Q1	$1.13M	Sell	168,896 -29,696	-15%	-$180K	﹤0.01%	1643
2013 Q4	$1.24M	Sell	198,592 -215,027	-52%	-$1.05M	﹤0.01%	1618
2013 Q3	$1.8M	Sell	413,619 -851,161	-67%	-$3.89M	0.01%	1355
2013 Q2	$5.59M	Buy	+1,264,780	New	+$5.6M	0.02%	816

Other funds holding SEM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

AQR Capital Management's SEM Position: Q2 2026 in Review

AQR Capital Management increased its Select Medical (SEM) stake by 52% in Q2 2026, buying an estimated $941K and bringing the position to 166,669 shares worth $2.75M. The position accounts for ﹤0.01% of the portfolio, ranked #2402.

AQR Capital Management first reported a position in SEM in Q2 2013 and has held it in 51 quarters since. The position peaked at $7.06M in Q4 2014. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

AQR Capital Management held 166,669 shares of Select Medical worth $2.75M as of Q2 2026.
AQR Capital Management bought 57,085 Select Medical shares in Q2 2026, an estimated $941K.
Select Medical made up ﹤0.01% of AQR Capital Management's portfolio in Q2 2026, its #2402 holding.
AQR Capital Management first reported a position in Select Medical in Q2 2013 and has held it in 51 quarters since.
AQR Capital Management's Select Medical position peaked at $7.06M in Q4 2014.
238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.